About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD55.50
- USD59.00
- USD53.71
- USD59.00
- 44.50%
- 19M
- 15.64k
- 19.22k
- 117M
- 4.02
- 422.50%
Stock News
yesterday
U.S. stock futures dip ahead of a busy week on Wall Street
MarketWatch
yesterday
Here are the 3 big things we're watching in the stock market in the week ahead
CNBC
yesterday
ICE Minneapolis shooting: Noem calls Good's actions ‘domestic terrorism’
CNBC
yesterday
3 ways parents can lower kids' screentime, from the co-author of 'The Amazing Generation'
CNBC